|
⚲
|
| Keyboard |
| Drake Peter F
✚
|
|
|---|---|
| CIK # | 0001267854 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001267854] | |
| 4 | [0001267854] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Drake Peter F | |
| Trevi Therapeutics Inc | |
| Navidea Biopharmaceuticals Inc | |
| Cortex Pharmaceuticals Inc/De/ |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Trevi Therapeutics Inc TRVI
Common Stock
|
2019-05-09 | Conversion | 62,540 | ||
|
Trevi Therapeutics Inc TRVI
Series A Preferred Stock · derivative
|
2019-05-09 | Conversion | 133,153 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Series C Preferred Stock · derivative
|
2019-05-09 | Conversion | 376,023 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2015-07-16 | Disposed to issuer | 22,000 | $0.01 | 220 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2015-03-26 | Grant | 22,000 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2015-02-05 | Grant | 7,606 | $1.89 | 14,375 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2014-11-10 | Grant | 10,973 | $1.32 | 14,484 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2014-02-13 | Grant | 20,000 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2013-02-21 | Grant | 12,250 | $0.00 | |
|
Cortex Pharmaceuticals Inc/De/ COR
Options to Purchase Common Stock · derivative
|
2012-08-03 | Grant | 30,000 | $0.00 | |
|
Cortex Pharmaceuticals Inc/De/ COR
Options to Purchase Common Stock · derivative
|
2012-08-03 | Grant | 346,667 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2012-04-10 | Grant | 17,000 | $0.00 |